Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | FBP1 | P09467 | 1/20 | 0.52 |
| ▸ | SNCA | P37840 | 1/20 | 0.51 |
| ▸ | MAOB | P27338 | 3/20 | 0.50 |
| ▸ | MAOA | P21397 | 2/20 | 0.50 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.50 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9803853 | 1.00 | ALDH1A1 (0.59) | ALDH1A1MAPTLMNAL3MBTL1TSHR | |
| SCHEMBL11486259 | 1.00 | ALDH1A1 (0.59) | ALDH1A1MAPTLMNAL3MBTL1TSHR | |
| SCHEMBL700237 | 1.00 | ALDH1A1 (0.59) | ALDH1A1MAPTLMNAL3MBTL1TSHR | |
| Bromide SCHEMBL10654452 | 0.98 | ALDH1A1 (0.58) | ALDH1A1MAPTLMNAL3MBTL1TSHR | |
| Bromide SCHEMBL10654444 | 0.98 | ALDH1A1 (0.58) | ALDH1A1MAPTLMNAL3MBTL1TSHR | |
| (Z)-1,2-Diphenylethene SCHEMBL28593492 | 0.93 | TSHR (0.70) | ALDH1A1MAPTLMNAL3MBTL1TSHR | |
| SCHEMBL1687899 | 0.92 | NR1H3 (0.56) | ALDH1A1MAPTLMNAL3MBTL1TSHR | |
| SCHEMBL11329021 | 0.91 | MAOB (0.61) | ALDH1A1MAPTLMNAL3MBTL1TSHR | |
| SCHEMBL11329024 | 0.91 | MAOB (0.61) | ALDH1A1MAPTLMNAL3MBTL1TSHR | |
| SCHEMBL8699093 | 0.90 | FBP1 (0.59) | ALDH1A1MAPTLMNAL3MBTL1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0358476-B1 | Integrated optic components | AKZO NOBEL NV (NL) | 1998-07-22 | — | — | EP | claimed |
| US-5470692-A | Integrated optic components | AKZO NOBEL N.V. (NL) | 1995-11-28 | — | — | US | claimed |
| US-5142605-A | INTEGRATED OPTIC COMPONENTS | BARR & STROUD LIMITED (GB) | 1992-08-25 | — | — | US | claimed |
| EP-0358476-A2 | Integrated optic components | Akzo Nobel N.V. (NL) | 1990-03-14 | — | — | EP | claimed |
| US-12404221-B2 | Methods of arene alkenylation | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2025-09-02 | — | — | US | disclosed |
| US-20230234900-A1 | METHODS OF ARENE ALKENYLATION | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2023-07-27 | — | — | US | disclosed |
| US-20230234900-A1 | METHODS OF ARENE ALKENYLATION | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2023-07-27 | — | — | US | disclosed |
| US-20230234900-A1 | METHODS OF ARENE ALKENYLATION | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2023-07-27 | — | — | US | disclosed |
| WO-2022060378-A1 | INTRAOCULAR LENS | CARL ZEISS MEDITEC AG (DE) | 2022-03-24 | — | — | WO | disclosed |
| EP-2909130-B1 | CATALYSIS BY METAL NANOPARTICLES DISPERSED WITHIN A HIERARCHICALLY POROUS CARBON MATERIAL | BAKKER MARTIN (US) | 2022-01-26 | — | — | EP | disclosed |
| WO-2021074275-A1 | EFFECTIVE PHOTOMODULATION OF LANTHANIDE (III) ION LUMINESCENCE IN THE VISIBLE OR NEAR-INFRARED RANGE | UNIVERSITE DE RENNES 1 (FR) | 2021-04-22 | — | — | WO | disclosed |
| US-9925153-B2 | Therapeutic agents for skin diseases and conditions | STC.UNM (US) | 2018-03-27 | — | — | US | disclosed |
| US-4259482-A | NON-SPECIFIC DEPRESSION OF CENTRAL NERVOUS SYSTEM | MEAD JOHNSON & COMPANY (US) | 1981-03-31 | — | — | US | disclosed |
| US-4217301-A | Cyano-substituted stilbene compounds | CIBA-GEIGY CORPORATION (US) | 1980-08-12 | — | — | US | disclosed |
| US-4206142-A | REACTING A STYRYLSULFONYLAMIDINE WITH A BASE | MEAD JOHNSON & COMPANY (US) | 1980-06-03 | — | — | US | disclosed |
| US-4130663-A | ANTITHROMBOGENIC, ANTIHYPERTENSIVE | MEAD JOHNSON & COMPANY (US) | 1978-12-19 | — | — | US | disclosed |
| US-4097515-A | Process for the manufacture of cyano-substituted stilbene compounds | CIBA-GEIGY CORPORATION (US) | 1978-06-27 | — | — | US | disclosed |
| US-4096183-A | Styrylsulfonylamidines | MEAD JOHNSON & COMPANY (US) | 1978-06-20 | — | — | US | disclosed |
| US-4052455-A | ANALGESICS, BLOOD PLATELET AGGREGATION INHIBITORS | MEAD JOHNSON & COMPANY (US) | 1977-10-04 | — | — | US | disclosed |
| US-4008224-A | OPTICAL BRIGHTENER | CIBA-GEIGY CORPORATION (US) | 1977-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234900-A1 | METHODS OF ARENE ALKENYLATION | CYBB, CBR3, AHR | ALDH1A1 414/4885MAPT 4342/4885LMNA 1425/4885 |
| US-12404221-B2 | Methods of arene alkenylation | CYBB, CBR3, AHR | ALDH1A1 414/4885MAPT 4342/4885LMNA 1425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.